Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 20 Aug 2026
Showing 10 of 27 filings.
20 Aug 20264 filings
Company UpdateChange in Management

Satish G. Thakur re-appointed as Chairman and Whole-time Director for a three-year term from 24 June 2026.

Chairman & WTD re-appointment

  • Re-appointment of Satish G. Thakur as Chairman and Whole-time Director.
  • Term: three-year tenure from 24 June 2026.
  • Approval by AGM held on 20 August 2026.
  • Profile: B.Sc., L.Tech; 43 years' industry experience; involved in operations since incorporation.
  • Relationship: Father of Rishikesh Thakur, MD.
  • Effective date: 24 June 2026.
Filed 20:15View Source
Company UpdateChange in Management

Link Pharma Chem Re-appoints Rishikesh Thakur as Managing Director for three-year term from 24 September 2026

MD Re-appointment

  • Re-appointed as MD for three years from 24 September 2026, approved at AGM 20 August 2026.
  • Profile: B.E. Polymer; 15+ years in chemical business; former GM-Operations.
  • Relationship: Son of Satish G. Thakur, Chairman & Whole-time Director.
Filed 20:13View Source
AGM/EGMAGM

Link Pharma Chem Ltd's 41st AGM: all resolutions approved including director re-appointments and auditor actions

AGM details

  • AGM held on 20 August 2026 at 11:40 AM via VC/OAVM.
  • Record date: 13 August 2026.

Key resolutions

  • Resolution 1: Adopt audited financial statements for year ended 31 March 2026; passed.
  • Resolution 2: Re-appoint Satish Thakur as director by rotation; passed.
  • Resolution 3: Ratify remuneration of Cost Auditors for FY 2026-27; passed.
  • Resolution 4: Appoint Secretarial Auditor; passed.
  • Resolution 5: Re-appoint Satish Thakur as Chairman & Whole-time Director; passed.
  • Resolution 6: Re-appoint Rishikesh Thakur as Managing Director; passed.

Voting results

  • Resolution 1: 99.74% in favour, 0.26% against.
  • Resolution 2: 99.74% in favour, 0.26% against.
  • Resolution 3: 99.74% in favour, 0.26% against.
  • Resolution 4: 99.74% in favour, 0.26% against.
  • Resolution 5: 99.74% in favour, 0.26% against.
  • Resolution 6: 99.74% in favour, 0.26% against.

Director changes

  • Satish Thakur re-appointed as Chairman & Whole-time Director.
  • Rishikesh Thakur re-appointed as Managing Director.

Auditor appointments/remuneration

  • Secretarial Auditor appointed.
  • Cost Auditor remuneration ratified for FY 2026-27.
Filed 19:56View Source
AGM/EGMAGM

Link Pharma Chem 41st AGM held via VC on 20 August 2026 with six resolutions

AGM Details

  • 41st AGM held on 20 August 2026 at 11:40 a.m. via VC/OAVM.
  • Meeting duration 11:40 a.m. to 12:05 p.m.
  • Quorum: 47 members attended via VC.

Key Resolutions

  • Adoption of Audited financial statements for FY 2025-26 and reports.
  • Re-appointment of Satish Thakur as director (retiring by rotation).
  • Ratification of Cost Auditors’ remuneration for 2026-27.
  • Appointment of Secretarial Auditor.
  • Re-appointment of Satish G. Thakur as Chairman & WTD.
  • Re-appointment of Rishikesh Thakur as Managing Director.

Voting Process

  • Remote e-voting conducted 17–19 August 2026; on-site AGM voting also available.
  • Scrutinizer to file report; results to be posted on company website.

Attendees & Auditors

  • Directors present via VC included Chairman Satish Thakur, MD Rishikesh Thakur, and independent directors.
  • In attendance: CFO, Company Secretary, Statutory Auditor, Secretarial Auditor.
  • Statutory auditors CNK & Associates LLP attended; no change in statutory audit.
Filed 18:57View Source
6 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper publication of Unaudited Financial results of the Company for the Quarter ended June 30, 2026 published on 06th August, 2026 in Business Standard (English edition) and Loksatta ....

Filed 18:28View Source
28 Jul 20263 filings
Company UpdateGeneral

Link Pharma Chem sets 41st AGM for 20 August 2026; annual report link dispatched to non-email shareholders

AGM & Annual Report Access

  • AGM: 41st AGM on 20 August 2026 at 11:30 IST via VC/OAVM.
  • Cut-off for e-voting: 13 August 2026; remote voting 17–19 August 2026.
  • Letter dispatched to shareholders without registered emails; web-link to Annual Report sent.
  • Annual Report 2025-26 available online at https://linkpharmachem.co.in.

KYC & Shareholder Communications

  • KYC/update reminder for physical shareholders per SEBI circular 2024/37, cut-off 24 July 2026.
  • SEBI circular requires PAN, contact details, nomination updates; electronic payments mandated if folios lack updates.
Filed 18:31View Source
Company UpdateNewspaper Publication

Newspaper advertisement of Notice of 41st Annual General Meeting.

Filed 18:14View Source
Board Meeting

Link Pharma Chem to consider unaudited Q1 2026 results; trading window closure notified.

Meeting Details

  • Date: 05 August 2026; time and venue not disclosed.

Key Agenda Items

  • Consider and approve unaudited standalone financial results for the quarter ended June 30, 2026.

Other Notes

  • Trading window closed from 01 July 2026; opens 48 hours after results declaration.
  • Intimation to BSE about the meeting provided on 26 June 2026.
Filed 15:21View Source
27 Jul 20262 filings
Corp. ActionBook Closure

Link Pharma Chem books closure for 41st AGM with 13 Aug 2026 e-voting cutoff

Book closure for AGM

  • Book closure from 14 August 2026 to 20 August 2026 (both days inclusive) for AGM.
  • Purpose: record date for 41st Annual General Meeting.
  • Cut-off date for remote e-voting: 13 August 2026; entitles voting shareholder names.
  • AGM date and time: 20 August 2026 at 11:30 A.M. via VC/OAVM.
  • Security: equity shares.
Filed 18:38View Source
OthersReg. 34 (1) Annual Report

Link Pharma Chem Limited: FY2025-26 Annual Report

Financial performance

  • Revenue from operations: ₹2,743.15 Lakh; up 7.86% YoY from ₹2,543.34.
  • Total income: ₹2,763.49 Lakh.
  • Profit after tax: ₹7.69 Lakh; PAT margin 0.28%.
  • Earnings per share: ₹0.17.

Revenue mix & customers

  • Domestic sales: ₹1,376.92 Lakh; export: ₹118.03 Lakh; conversion charges: ₹1,248.11 Lakh.
  • Top four customers accounted for ₹1,770.31 Lakh in FY26.
  • Single chemicals segment; one manufacturing unit in Gujarat.

Capital structure & liquidity

  • Total borrowings: ₹730.42 Lakh; long-term ₹69.51; current ₹660.90; net debt ₹591.15.
  • Gearing ratio 0.32x; cash ₹54.59; unused WC facilities ₹245.44.
  • Loans secured; personal guarantees by MD and WTD; collateral includes land/building & machinery.

Dividends & capital moves

  • Transfer to reserves: none.
  • Equity share capital: ₹444.06 Lakh; 4,440,568 shares.

Governance & audit

  • Board: Satish Thakur (Chairman), Rishikesh Thakur (MD), independent directors Ghai, Shah, Gada.
  • Khushbu Patel resigned Dec 2025; Komal Bhojwani appointed Jan 2026.
  • Secretarial Auditor: Vijay Bhatt & Co appointed 2026–2030; no qualifications.
  • Statutory auditors: CNK & Associates LLP; no ratification required.

Risks & outlook

  • Crude oil and feedstock price volatility affects margins.
  • Gulf region tensions impact raw material pricing; GPCB compliance.
  • Outlook: develop new products for domestic and international demand.

Contingent liabilities & commitments

  • GST disputes ₹154.59 Lakh.
  • Bank guarantee ₹5.90.
  • Capital commitments: contracts pending ₹4.45 Lakh.

Related party disclosures

  • Key KMP remuneration: Satish Thakur ₹48 Lakh; Rishikesh Thakur ₹36 Lakh.
  • Year-end payables include MD ₹2.78 Lakh; Rishikesh Thakur ₹2.08 Lakh.
Filed 16:14View Source
Showing 10 of 27 filings